Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma files for $150M mixed securities shelf offering, including a new ATM offering of up to $60M. The company also reiterates a Buy rating with a $17.00 price target, citing the NXP900 Phase 1b trial.
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. is a biopharmaceutical company focused on developing and deploying advanced technological solutions.
Nuvectis Pharma, Inc. uses the ticker $NVCT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Nuvectis Pharma, Inc. (NVCT) trading volume is up 643.81% from the previous month.
- Nuvectis Pharma, Inc. (NVCT) social dominance is up 175% from the previous week.
- Nuvectis Pharma, Inc. (NVCT) engagements is up 136.05% from the previous week.
- Nuvectis Pharma, Inc. (NVCT) posts created is up 100% from the previous week.
- Nuvectis Pharma, Inc. Price hit a 52-Week high of $9.50 for the hour
- Nuvectis Pharma, Inc. Price hit an all time of $9.50 for the hour
Price: $8.80
Price 24-Hour Time-Series Raw Data
The current upward price action, reaching a 52-week high, is likely driven by significant surges in social media engagement and positive sentiment, particularly around the anticipated NXP900 drug data and a recent mixed securities shelf offering.
24-Hour: -0.45% 7-Day: -0.91% 30-Day: 3.3%
1-Year High: $9 on 2026-02-09
1-Year Low: $5.70 on 2025-11-05
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Nuvectis Pharma, Inc. (NVCT) is currently AltRank #1,230 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [---]
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2026-02-16
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +2
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-01-24
1-Year Low: [--] on 2025-04-25
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] +136%
[--] Month: [------] +40%
[--] Months: [-------] -38%
[--] Year: [-------] -16%
1-Year High: [------] on 2025-06-20
1-Year Low: [--] on 2025-08-24
Engagements by network (24h): YouTube: [--] X: [---] Reddit: [--] News: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -3.70%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-05-25
Mentions by network (24h): YouTube: [--] X: [--] Reddit: [--] News: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Nuvectis Pharma, Inc. (NVCT) in the last [--] hours which is down 3.70% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -3.60%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-06-05
The most influential creators that mention Nuvectis Pharma, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @indian20062 | [--] | [--] | [--] | [--] |
| @DalvinVarnado | [--] | [------] | [--] | [--] |
| @JD4for4 | [--] | [-----] | [--] | [--] |
| @USA_Trader03 | [--] | [--] | [--] | [--] |
| @EVAJONE38478931 | [--] | [--] | [--] | [--] |
| @Ella55005 | [--] | [--] | [--] | [--] |
| @BentMatild48050 | [--] | [--] | [--] | [--] |
| @tradingsssss | [--] | [-----] | [--] | [--] |
| @Lola_La_Fleur_ | [--] | [--] | [--] | [--] |
| @BillMiller32 | [--] | [-----] | [--] | [--] |
Sentiment: 69%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 69%
Daily Average: 71%
[--] Week: 50% -20%
[--] Month: 50% +19%
[--] Months: 50% -50%
[--] Year: 50% -50%
1-Year High: 100% on 2025-02-20
1-Year Low: 4% on 2026-01-19
Most Supportive Themes:
- Technological Innovation: (40%) Posts highlighting new product developments and research breakthroughs.
- Industry Leadership: (30%) Content showcasing Nova Cadrus Technologies' influence and expertise in the tech sector.
Most Critical Themes:
- Market Competition: (25%) Discussions and analyses comparing Nova Cadrus Technologies with its competitors.
- Regulatory Landscape: (5%) Information and opinions regarding the impact of new regulations on the company's operations.
Social Dominance: 0.0059%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0059%
Daily Average: 0.00374%
[--] Week: 0.0099% +0.0063%
[--] Month: 0.0064% -0.014%
[--] Months: 0.0064% +0.0047%
[--] Year: 0.0064% +0.0017%
1-Year High: 0.03% on 2025-06-29
1-Year Low: 0.0003% on 2025-08-25
Market Dominance: 0.00026287938368515715%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00026287938368515715%
Daily Average: 0%
1-Year High: 0.011% on 2026-02-06
1-Year Low: 0.00026% on 2026-02-16
Market Cap: $232,067,310
Market Cap 24-Hour Time-Series Raw Data
Current Value: $232,067,310
Daily Average: $222,576,351
[--] Week: $232,332,227 +0.67%
[--] Month: $232,067,310 +6.80%
1-Year High: $239,484,986 on 2026-02-09
1-Year Low: $207,736,807 on 2026-01-20
Top Nuvectis Pharma, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$NVCT: Nuvectis Pharma files for $150 mln mixed securities shelf offering https://www.briefing.com/in-depth-analysis/Content/ArticleArticleId=IN20260213160622NVCT&utm_campaign=inplay&utm_medium=social&utm_source=twitter&utm_content=view_page https://www.briefing.com/in-depth-analysis/Content/ArticleArticleId=IN20260213160622NVCT&utm_campaign=inplay&utm_medium=social&utm_source=twitter&utm_content=view_page"
X Link @Briefingcom 2026-02-13T23:07Z 34.5K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing